BioSpace News Archive

Karyopharm Therapeutics Inc. and the Menarini Group (“Menarini”) today announced that the United Kingdom’s (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has granted full Marketing Authorization for NEXPOVIO.

NextPoint Therapeutics announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).

Cognito Therapeutics , a clinical-stage neurotechnology company, announced today the first patient enrollment in its US pivotal study (HOPE), designed to demonstrate the safety and efficacy of its proprietary non-invasive stimulation device CogTx-001 in patients with Alzheimer’s Disease.

EV Biologics Corp (OTC PINK:YECO), today announced that it has successfully generated several mesenchymal stem/stromal cell (MSC) lines for secretome production and further cell line development.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”) announces the appointment of Mr. Evan Ballantyne to the Company’s board of directors (the “Board”) effective February 17, 2023.

Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce that it signed an agreement with City of Hope National Medical Center and Beckman Research Institute of the City of Hope,

Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial results prior to the market open on Monday, March 6, 2023.

eFFECTOR Therapeutics, Inc. today announced top-line results from its Phase 1b clinical trial of zotatifin for the treatment of COVID demonstrating favorable safety results as well as positive trends in several measures of antiviral activity.

Predictive Oncology Inc. announced the launch of ACE, a program to advance the oncology drug development initiatives with academic and research institutions.

Yield10 Bioscience, Inc., an agricultural bioscience company, announced key advancements for enabling weed control for Camelina cultivation and for supporting grower adoption of this crop for the biofuel feedstock oil market.